Tutorial Session I: Moseley and Richardson

June 3, 2018

The ASMS conference will offer two parallel tutorial sessions on Sunday evening.

The ASMS conference will offer two parallel tutorial sessions on Sunday evening. The first of these includes talks from M. Arthur Moseley of Duke University of Medicine and Susan D. Richardson of the Univers

Moseley will talk about strategies for quantitative proteomics. Moseley is the Director of Proteomics for the School of Medicine at Duke. There, he develops and applies proteomic technologies for qualitative and quantitative analyses using nanoscale ultrahigh-performance liquid chromatography combined using high resolution, accurate mass tandem mass spectrometry (UHPLC–HRMS/MS). The principal goal of his research is to increase the impact of proteomics on the basic and clinical sciences, with an emphasis on translational research leading to direct improvements in patient care. His work also addresses improvements in methods for data collection using an optimized, systematic, and standardized approach to data collection to permit the direct comparison of results across experiments, across projects, and across laboratories.

Richardson’s talk will focus on mass spectrometry in the environment. Richardson is the Arthur Sease Williams Professor of Chemistry at the University of South Carolina. The primary focus of her work is identifying new disinfection byproducts (DBPs) in drinking water, determining formation mechanisms, and integrating toxicological characterization with chemical characterization approaches. DBPs are formed when disinfectants used at water treatment plants (such as chlorine, chloramines, ozone, and chlorine dioxide) react with naturally occurring organic matter, bromide, and iodide. They can also form through the reaction of disinfectants with anthropogenic contaminants, such as pharmaceuticals and personal care products, hormones, and pesticides. Human epidemiologic studies conducted in the United States and in other countries have shown increase risk for bladder cancer and the potential for early-term miscarriage and birth defects in some locations, and the DBPs responsible for these effects are currently not known.

This session will be held from 5:00 to 6:30 in Hall D, on the ground level. Moseley will talk from 5:00 to 5:45, followed by Richardson from 5:45 to 6:30 p.m.